Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin

Authors not listed

University of Roma La Sapienza · 2020

Abstract

This is a multicenter, observational, retrospective and prospective study for the evaluation of precision medicine to target frailty of endocrine-metabolic origin, with a genetic study.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Anonymous. (2020). PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin. <em>University of Roma La Sapienza</em>. https://clinicaltrials.gov/study/NCT04856683
Vancouver
Anonymous. PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin. University of Roma La Sapienza. 2020.
BibTeX
@misc{anon2020PRecis, title = {PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin}, author = {Anonymous}, journal = {University of Roma La Sapienza}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings